NCT06284031Recruiting
Cervical Cancer Brachytherapy With Interstitial Needles in 3 Fractions
Cervical Cancer Brachytherapy With Interstitial Needles in 3 Fractions: Dosimetric and Clinical Outcomes
Source: ClinicalTrials.gov · Last updated 28 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Aim To determine the feasibility and safety of 3 fractions of high dose rate (HDR) brachytherapy with interstitial needles for cervical cancer in the outpatient setting Primary objective To determine the clinical outcome (2-yr local control rate, loco-regional control rate, progression free survival and overall survival) Secondary objective To determine the long-term toxicities of this regimen based on CTCAE v5
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 56 (estimated)
- First submitted
- 25 Jul 2023
- Start date
- 26 Jun 2023
- Primary completion date
- Jun 2026
- Lead sponsor
- National University Hospital, Singapore
- Diseases
- Cervical cancer
- NCT number
- NCT06284031
What you commit to
- Study type: Interventional
- Planned participants: 56
- From 26 Jun 2023 to the primary completion date, Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Post operative cervical cancer cases
Other
- Pregnant or breastfeeding women
Who the study is looking for
- 21 years old and above
- Histologically proven squamous cell carcinoma, adenocarcinoma, adenosquamous or poorly differentiated cervical cancer
- Clinically or radiologically stage IB - IVA cervical cancer based on TNM 8th Edition
- ECOG performance status 0, 1, or 2
- To complete external beam radiotherapy and brachytherapy in NUH
- Written, voluntary informed consent
- Patients must be accessible for follow up and management in NUH
Age in the registry: 21 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National University Hospital Coordinator of this site? Confirm its status | Singapore | Singapore | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.